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Glomerular charge alterations in human minimal change nephropathy.
A theoretical model of charge and size selectivity for the glomerulus has
been applied to human data. Using previously published values for
GFR, renal plasma flow, systemic oncotic pressure, and fractional
clearances of neutral dextrans, albumin, salivary amylase, and transfer-
rin, membrane parameters describing the glomerular barrier were
determined for normal individuals under control conditions and during
lysine infusion (which retards tubule protein reabsorption), and for
patients with minimal change nephropathy (MCN). To permit the
estimation of membrane charge from fractional clearances, molecular
charge values for human transferrin (—9.4 Eq/mole) and human salivary
amylase (—4.1) were determined by measuring electrophoretic mobil-
ities of these proteins in polyacrylamide gels. Assuming no large
changes in the transmural hydraulic pressure difference (P), the
glomerular ultrafiltration coefficient (Kf, the product of hydraulic
permeability and capillary surface area) was calculated to be reduced by
>50% in MCN. The effective pore radius (—55 A) is virtually unaltered
in MCN, suggesting that the decline in Kf is due to a reduced number of
pores. The degree of albuininuria observed in MCN is attributable to an
approximately 50% reduction in the concentration of fixed negative
charges in the glomerular capillary wall. The concentrations of fixed
charges calculated from albumin data in normal individuals (140 to 160
mEq/Iiter) and in patients with MCN (60 to 90 mEq/liter) are insensitive
to the assumed values of P.
Alterations de Ia charge glomerulaire dans Ia nephropathie humaine a
lesions minimes. Un modèle theorique pour Ia sélectivité par Ia charge et
Ia taille pour le glomerule a été appliqué aux données humaines. En
utilisant des valeurs déjà publiées pour le GFR, Ic debit plasmatique
renal, Ia pression oncotique systémique, et les clearances fractionnelles
de dextrans neutres, d'albumine, d'amylase salivaire et de transferrine,
les parametres membranaires décrivant Ia barrière glomérulaire ont été
déterminés pour des individus normaux, dans des conditions contrôles,
et pendant une perfusion de lysine (qui retarde Ia reabsorption tubulaire
des protéines), et chez des malades ayant une nephropathie a lesions
glomérulaires minimes (MCN). Afin de permettre l'estimation de Ia
charge membranaire a partir des clearances fractionnelles, les valeurs
de Ia charge moléculaire de Ia transferrine humaine (—9,4 Eq/mole) et
de l'amylase salivaire humaine (—4,1) ont étd déterminées en mesurant
Ia mobilité electrophoretique de ces protéines sur des gels de polyacryl-
amide. En postulant qu'il n'y a pas de grandes modifications dans Ia
difference de pression hydraulique transmurale (P), le coefficient
d'ultrafiltration glomerulaire (Kf, produit de la permCabilité hydraulique
et de Ia surface capillaire) apparait par Ic calcul être réduit de <50%
dans Ia MCN. Le rayon effectif des pores (—55 A) est virtuellement
inchange dans Ia MCN, suggérant que Ia diminution de Kest due a une
diminution du nombre des pores. Le degre d'albuminurie observe dans
Ia MCN est attribuable a une reduction d'environ 50% de Ia concentra-
tion des charges negatives fixCes sur la paroi capillaire glomerulaire.
Les concentrations de charges fixées calculées a partir des données
obtenues avec l'albumine chez des individus normaux (140 a 160 mEq/
litre), et chez des patients avec une MCN (60 a 90 mEq/litre) sont
insensibles aux valeurs supposées de AP.
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A number of studies in rats have demonstrated that molecular
charge, in addition to molecular size, is an important determi-
nant of the glomerular filtration of macromolecules. It has been
shown by using various derivatives of dextran [1—3], ferritin [4,
5], and horseradish peroxidase [6], ranging in charge from
cationic to anionic, that the filtration of polyanions is reduced,
and that of polycations enhanced, relative to that of neutral
macromolecules of comparable size and structure. The need to
account for effects of both molecular size and charge has
motivated development of a theoretical model which treats the
glomerular capillary wall as an isoporous membrane containing
a certain density of fixed negative charges [7]. In this model the
filtration barrier is characterized completely by three parame-
ters: the ultrafiltration coefficient (Kf, product of hydraulic
permeability and capillary surface area), the effective pore
radius (r0), and the apparent concentration of fixed negative
charges (Cm). These quantities have been estimated for normal
rats and for rats with certain forms of experimental glomerular
injury leading to proteinuria [7, 8].
In rats with nephrotoxic serum nephritis (NSN) and puromy-
cm aminonucleoside nephrosis (PAN), it has been found that
the filtration of neutral dextran is decreased while the transport
of anionic dextran sulfate is increased [9—11]. This suggests that
the increased filtration of albumin and other anionic proteins in
these experimental disorders is due to the depletion of mem-
brane charge, rather than increases in the number or size of
pores. Calculated values Of Cm declined from a normal range of
120 to 170 mEq/liter to 25 mEq/liter in NSN and 100 mEq/Iiter in
PAN [7]. Ultrastructural studies employing various cationic
stains qualitatively confirm a reduction in fixed charge content
in these and other proteinuric disorders, including minimal
change nephropathy in man [10, 12—14].
Previous studies in humans, to our knowledge, have not
attempted to model the effect of membrane charge on macro-
molecule filtration in health or disease. Quantification of mem-
brane charge alterations should allow a clearer comparison of
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various disease entities and may well have implications for
therapy and pathogenesis. Accordingly, in this study we esti-
mate membrane charge in humans in health and minimal change
nephropathy (MCN), a condition of particular interest since
recent data suggest that proteinuria in this disorder results
entirely from a reduction in the fixed charge density of the
glomerular capillary wall [141. Furthermore, the selective pro-
teinuria characteristic of MCN [14, 15] and the failure to find an
increased clearance of large neutral molecules in MCN [161
suggest that it can be realistically represented using the isopor-
ous model that has been applied to the rat. The analysis of
membrane charge presented here is based necessarily on data
for certain endogenous plasma proteins, since no other charged
test macromolecule (such as dextran sulfate) has been available
for human use. We use previously published clearance data for
albumin, transferrin, and salivary amylase obtained under nor-
mal conditions [17, 18], during the inhibition of tubule protein
reabsorption with lysine [171 and in MCN [15]. Clearances of
neutral dextran in health and MCN are also used in the
calculations [151. Molecular charge estimates for two of the
proteins, transferrin and amylase, have not been available
previously and were obtained from electrophoretic mobility
measurements reported here. We show that despite uncertain-
ties stemming from protein reabsorption and the inaccessibility
of the human glomerulus to direct measurement of pressures
and flows, probable ranges of Cm in health and MCN can be
estimated with reasonable confidence. These values of Cm for
humans prove to be quite similar to those reported previously
for the rat [7, 8].
Methods
Calculation of membrane parameters. The fixed-charge mod-
el of Deen, Satvat, and Jamieson [7] was used to estimate
values for the membrane parameters, Kf, r0, and Cm. Since the
model has been described in detail elsewhere, only a brief
summary of the governing equations and assumptions is pre-
sented here. The model assumes that the glomerular capillary
can be described as a tube of constant circumference, the wall
of which is perforated by pores of radius r0 and length 8. S
refers to total capillary surface area and y denotes normalized
axial position along a capillary (y = 0 at afferent end, and y =
at efferent end)1. The membrane is assumed to contain a
concentration Cm of fixed negative charges. The primary effect
of these fixed charges is to impose Donnan potentials at the
plasma and Bowman's space membrane interfaces, the intra-
membrane potential being negative relative to either of the
external solutions. Potential differences within the membrane
are negligible [71.
Mass balance equations. Under the assumptions given
above, the following differential equations relate the changes in
plasma flow rate (Q) and concentration of solute i (C1) with
position along a glomerular capillary to the fluxes of volume (J)
and solute i (J1) from plasma to Bowman's space:
(1)
(2)
The initial conditions required are the afferent values of plasma
flow rate (QA) and solute concentration (CIA). Equation 2 is
applied to three solutes: total protein, sodium, and the test
macromolecule (dextran or specific protein). For total protein,
the right side of equation 2 is set equal to zero, based on the
assumption that the total amount of protein filtered is a very
small fraction of that presented to the kidney in afferent plasma.
This assumption is supported by the data of Carrie, Salyer, and
Myers 1141 and Carrie and Myers [15] in MCN, which indicate
this fraction to be less than —-l0 even at the nephrotic levels
of proteinuria studied.
Flux equations. The small fractions of protein filtered justify
continued use of the Starling relation to describe the transcapil-
lary volume flux:
JS = K1(P — ITG) (3)
P is the transcapillary hydraulic pressure difference2 and IT
the intracapillary colloid osmotic pressure (calculated from
total protein concentration, C, using equation 8). Note from
equation I that only the product of J,,, and S is required. For a
solute of molecular charge z, and diffusion coefficient (in bulk
solution) D1, the flux is given by:
—
JC1Kc4 exp[z4i(0)I 4
1 — exp(—a) {l — Kcq exp[z1i(8)]}
where
Kc(LP — ITG)roa (5)
87JKDDI
In equation 4, the potential differences across the membrane
surfaces adjacent to the capillary lumen and to Bowman's space
are given by LiJi(0) and /i(6), respectively. These are the
magnitudes of the Donnan potentials at the respective mem-
brane interfaces and are positive numbers. Here (' is a dimen-
sionless potential, referenced to RT/F, where R is the universal
gas constant, T is the absolute temperature, and F is Faraday's
constant, In equation 5, s is the viscosity of water at 37°C. The
remaining quantities in equations 4 and 5 (Kc, KD, 4') all
involve hindrances to molecular transport based on the ratio of
molecular radius to pore radius. These functions describe the
size-selectivity of the capillary wall and are calculated from a
hydrodynamic theory of transport in pores [19]. For small
solutes such as sodium, Kc, KD, and 4' are approximately equal
to unity, whereas for large solutes they approach zero.
Evaluation of membrane parameters. For a given set of
membrane parameters (K1, r0, Cm) and other input quantities
the mass balance equations (equations 1 and 2) are integrated
numerically to determine all fluxes and concentrations as1This model is based on the assumption of identical capillaries in
parallel, so that the mass balance and flux equations apply equally well
to a single capillary, a single glomerulus, or the sum of all glomeruli,
depending on the interpretation of S and plasma flow rate (Q). The
single glomerulus is the most appropriate basis in the rat, since
micropuncture data are available at that level. In humans the natural
basis is the sum of all glomeruli in both kidneys.
21n this study P is assumed to be essentially independent of position
along a glomerular capillary, as suggested by findings in the rat [31].
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functions of y. This allows calculation of the ratio (9) of the
macromolecule concentration in Bowman's space to that in
afferent plasma, which is given by:
Jdy
(6)
CIA j J dy
It should be noted that for a solute that is not reabsorbed or
secreted, 0 equals the fractional clearance, the ratio of the
urinary clearance of ito that of inulin. Reabsorption of filtered
protein requires that a distinction be made between 9 and
urinary fractional clearance, denoted by 0,.
The ultrafiltration coefficient (Kr) is evaluated using the
combined solutions of equations 1 and 2 (the latter applied to
total protein), by matching the calculated efferent value of C, to
that measured. Since P is not directly measurable in humans,
values of Kf will be reported for various assumed values of P.
For a neutral macromolecule (z, = 0) of specified size, 9
depends only on Kf and pore radius (r0). With Kf already
determined as just described, r0 is estimated by adjusting its
value until the calculated value of 0 matches that observed. For
a charged macromolecule, 0 depends on one additional parame-
ter, the fixed charge concentration (Cm). Given an assumed
value of Cm, the Donnan potentials in equation 4 are calculated
by applying equation 2 to sodium and using conditions of
overall electroneutrality in each compartment [71. An iterative
procedure is then used to find the value of Cm that provides
the best fit to the value of 0 observed for the charged
macromolecule.
Estimation of molecular charge. Application of the fixed
charge model requires evaluation of the effective molecular
charge (z) of the macromolecule under consideration. We used
electrophoretic mobility measurements in polyacrylamide gels
to estimate z for human transferrin (Sigma Chemical Co., St.
Louis, Missouri) and for human salivary amylase (Sigma Chem-
ical Co.). A gel electrophoresis cell was fabricated to allow for
large and equal volumes (—3L) in the upper and lower buffer
chambers, to minimize pH variation due to the electrochemical
reactions. The power supply (model 500) and electrophoresis
reagents were obtained from Bio-Rad Laboratories, Richmond,
California. Buffer chambers were filled with sodium phosphate
buffer at pH 7.4 and 0.15 M ionic strength. The cell was
immersed in a large water bath and maintained at 37°C. Poly-
acrylamide gels of approximately 70 mm length were formed in
glass tubes (5 mm I.D. x 125 mm) by polymerization of
acrylamide in the presence of the cross linking agent N,N'-
methylene-bis-acrylamide (BIS) as described previously [7].
At the beginning of an electrophoresis run 100 d of a 20%
sucrose solution containing about 0.04 mg of protein was
layered carefully on top of each gel. Generally, 16 tubes were
used, four at each gel concentration. In one or two tubes at each
concentration, purified human serum albumin (Sigma Chemical
Co.) was used as a reference standard. The remaining tubes
were loaded with the protein being studied. Two sets of 16 tubes
were run for both transferrin and amylase. Gels with indistinct
bands and gels distorted during removal from the tubes were
discarded. The electrophoresis was interrupted at 40-mm inter-
vals; the pH in each buffer chamber was determined and
readjusted toward 7.4. This procedure resulted in a maximum
range of pH from 7.35 to 7.45 in both chambers throughout each
experiment. Electrophoresis was carried out for 180 mm for
transferrin and 240 mm for amylase at a power supply setting
delivering a constant current of 8.1 mA/tube. Standard protein
staining and destaining procedures with Coomassie blue [81
allowed the determination of the migration distances. The
monomeric albumin band (highest mobility) was used as the
reference. The relative mobility was determined at each gel
concentration by dividing the average migration distance of the
test protein by that of the albumin band.
Results at various gel concentrations3, G, were extrapolated
to zero gel concentration using the equation [20]:
in (Mai,/Mtest) = in (Malb/Mtest)o — KG (7)
where (MalblMtest) is the ratio of albumin mobility to that of the
test protein at gel concentration G, and (MaIb/Mtest)o is the
mobility ratio in the free solution. Here K is a constant that
represents the relative retarding influence of the gel and may be
positive or negative, according to whether the gel retards
albumin more or less than the test protein. The constants in
(Malb/Mtest)o, K, and the correlation coefficient r were calculat-
ed using linear regression, and the 95% confidence intervals for
the relative mobilities determined in standard fashion [21]. The
molecular charge for albumin at pH 7.4 (z =
—19) was calculat-
ed from potentiometric titration results corrected for chloride
binding [22, 23]. Given their free solution mobilities, relative to
albumin, the molecular charges of transferrin and amylase were
determined through application of the Henry-Gorin hard sphere
model for the migrating colloid [24, 25], an appropriate choice
for globular proteins.
Results
Electrophoretic mobility and molecular charge
Transferrin. Each gel contained a distinct band correspond-
ing to the major component. Faint bands of lower mobility,
present in some tubes, were not reliably detected and were
ignored. The results are summarized in Figure 1 and Table 1.
The mobility of albumin relative to transferrin at G = 0 is 2.12,
with a 95% confidence interval of (1.68, 2.70). The molecular
radius of transferrin used in this study (38 A), is the mean of two
values (36 A, 40 A) reported by Laurent and Killander [26].
These data allow estimation of the molecular charge of human
transferrin at physiologic pH as z = —9.4. The 95% confidence
interval for z shown in Table 1 is calculated from the confidence
interval for the relative free solution mobility.
Salivary amyiase. All gels contained one band of major
intensity. Additional bands of lower intensity were variably
present and were ignored. Since all electrophoretic variants of
salivary amylase are reported to have similar molecular weights
[27], and since serum amylase activity displays only one peak in
gel filtration chromatography [281, the major band is assumed to
have a molecular radius of 29 A, corresponding to that peak.
The results are summarized in Figure 2 and Table 1. The free
solution mobility of albumin relative to salivary amylase is 3.71
with a 95% confidence interval of (2.31, 5.98). The estimated
3Gel concentration (expressed as percent) is given by the total weight
of BIS and acrylamide per 100 ml solvent.
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molecular charge of salivary amylase at pH 7.4 is z = —4.1. The
finding here of only one major salivary amylase band on
electrophoresis is consistent with the results of Mayo and
Carlson [28], who found that the four salivary isoamylases
Protein (MaIh/Mtt)o Z
Albumin 1.00 —19 — 36
Transferrin 2.12 —9.4 (—7.4, —12) 38
Amylase 3,71 —4.1 (—2.6,—6.6) 29
consist of two isoamylases with isoelectric point (IEP) = 5.9,
and two isoamylases with IEP = 6.4. All four isoamylases,
however, formed a single composite band on disc gel electro-
phoresis, implying that the molecular charge of all salivary
isoamylases may be similar despite disparate isoelectric points.
This belief is consistent with the finding that all isoamylases,
both salivary and pancreatic, are cleared by the kidney to a
similar extent [18].
Analysis of human filtration data
Ultrafiltration coefficients, Kf. The pore radius as calculated
here is a function of both K1 and P. Under conditions of
filtration pressure disequilibrium (ITE < P, where ITE is the
efferent oncotic pressure), a unique value of Kf can be calculat-
ed for each assumed value of P. As filtration pressure equilib-
rium is approached (ITE P), the calculated value of K1 tends
toward infinity and only a minimum estimate can be obtained
reliably. Glomerular capillary oncotic pressure (ir0) and total
plasma protein concentration (Ce) are related as follows4:
= a1Cp + a2Cp2 (8)
where a1 = 1.629 mm HgI(gIdl) and a2 = 0.2935 mm Hg!(gIdl)2.
Cp in the afferent arteriole (CPA) was calculated from values of
systemic oncotic pressure reported by Carrie and Myers [15] in
normal individuals and in MCN. These values of CPA, together
with the other needed inputs reported in the same study, GFR
(inulin clearance) and renal plasma flow rate (RPF, estimated
from PAH clearance) are shown in Table 2. Mogenson and
Solling [171 reported that GFR and RPF did not change signifi-
cantly during lysine infusion in normal volunteers. Accordingly,
we have used the same values of CPA, GFR, and RPF in our
calculations for lysine infusion as for normal individuals. Cp in
the efferent arteriole (CPE) was obtained in each case from CPA
and filtration fraction (FF = GFR/RPF), using the relation:
ITE (from CPE and equation 8) averaged 25.5 mm Hg in MCN
and 39.0 mm Hg in healthy individuals.
The ultrafiltration coefficient, Kf, calculated for both MCN
and normal humans as a function of assumed P is illustrated in
Figure 3. These calculations demonstrate a marked reduction in
K1 in MCN at any assumed constant value of P. For P 40
Table I. Physico-chemical data for selected proteins
Effective
95% Confidence molecular
interval for z radius, A
Abbreviations: z, effective molecular charge; (Mah/Mte)o, mobility
ratio in the free solution.
4.0 —
3.0 —
2,O
1.0 I I I I
0 2 4 6 8 10
G, %
Fig. 1. Relative mobility of albumin to transferrin (M,h/M,fl) as a
function of gel concentration G, plotted on semilogarithmic coordi-
nates. The linear regression line shown has correlation coefficient r
—0.667. At G = 0, the relative free solution mobility is 2.12.
2.0 -
1.0 I I
0 2 4 6 8 10
G, %
Fig. 2. Relative mobility o,f albumin to amylase (M,bIM,) as a
function of gel concentration G, plotted on semilogarithmic coordi-
nates. The linear regression line shown has correlation coefficient r
—0.473. At G = 0, the relative free solution mobility is 3.71.
CPA
—
1 — FF (9)
4Equation 8, with the same values of a1 and a2, has been shown to be
applicable both in normal individuals and in MCN [371.
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Quantity
U Normal
Lysine
infusion
Minimal change
nephropathy
GFR, mllmin 99 99 80
RPF, mi/mm 513 513 371
CPA, g/dl 7.33 7.33 5.45
mm Hg 40 40 40
Kf, mi/mm mm Hg 19.7 19.7 4.29
r0, Aa 545 545 545
mEq/liter' 16.0 16.0 11.9
CNa, mEq/litero 152 152 152
0u albumind 1.7 X 10-6 5.7 X iO 1.75 X iO
Oij transferrind 1.3 x 106 1.1 x i0 —
0u amylased 1.8 x 10—2
mm Hg, K is reduced by >75% in MCN, and for zP = 50 mm
Hg, Kf is reduced by >50% relative to control. That P in MCN
varies little from normal values is suggested by micropuncture
measurements of glomerular and tubule hydraulic pressure in
normal and PAN rats [ilL At P = 40 mm Hg, on a two-kidney
basis, K = 19.7 ml/(min mm Hg) in normal man (Table 2). The
corresponding single nephron Kf = 0.16 nl/(sec mm Hg),
assuming 2 x 106 nephrons in the two kidneys. This is roughly
twice the typical K value in the rat [311. Note that for a single
nephron, K = kS, the product of the apparent hydraulic
permeability, k, and the total glomerular capillary surface area,
S. The average surface area of the human glomerulus has been
estimated at S = 0.0038 cm2 [29], twice the value for the rat
glomerulus [301. Thus, the hydraulic permeabilities of human
and rat glomeruli appear to be virtually identical.
Pore radius. Values of r0 were calculated as a function of iP
using the clearance data for neutral dextrans of Carrie and
Myers [15] for both MCN and controls, with the results shown
in Figure 4. In both cases r0 is in the approximate range of 50 to
60 A and changes by only about 10% over the range examined.
For the particular value of P = 40 mm Hg, which we have
chosen as a base case, identical values of r0 (54.5 A) are
obtained for normal individuals and MCN, as indicated in Table
2 and Figure 4. Values of r0 during lysine infusion were taken to
be the same as for normal individuals, at any assumed value of
LP.
Estimates of the membrane charge density, Cm. Values of the
glomerular membrane charge density in normal humans and
patients with MCN are estimated in Table 3. Values of the
Bowman's space-to-plasma concentration ratio (0) for transfer-
rin, albumin, and amylase are estimated from the urinary
fractional clearance (Ow) in normal subjects [17, 18], during
lysine infusion [17], and in MCN [15], and are given in Table 2.
Due to tubule protein reabsorption, these values underestimate
O and result in the calculation of upper bounds on Cm. As shown
in Table 3, the upper bound on the normal membrane charge
density, Cm, P 40 mm Hg, ranges from 220 to 480 mEq/liter
for the three macromolecules. These upper bounds are higher
than the estimated values for normal Munich-Wistar rats, which
range from 100 to 170 mEq/liter, based on both micropuncture
24 28 32 36 40 44 48 52
P,mm Hg
Fig. 3. Whole kidney ultrafiltration coefficient K, as a function of the
assumed value of zP in normal man (NL) and in minimal change
nephropathy (MCN), on the basis of the parameters in Table 2.
data for albumin and fractional clearances of anionic, neutral,
and cationic dextrans [7, 8].
Mogenson and SoIling [17] interpreted their results from
lysine infusion in normal volunteers as showing near complete
inhibition of tubule reabsorption of albumin and a variety of
other proteins. As already mentioned, the model input values
used for the lysine infusion group are assumed to be identical to
the normal group with the exception of the values for 0 (Table
2). The upper bounds on Cm during lysine infusion (160 to 260
mEq/liter, Table 3) are much lower than the upper bounds
computed without the inhibition of protein reabsorption (220 to
480 mEq/liter), and presumably are a much closer approxima-
tion to actual charge values for normal individuals. In MCN, the
upper bound on Cm (90 mEqlliter) computed from the urinary
clearance of albumin is substantially lower than the value of 160
mEq/liter obtained for albumin during the inhibition of tubule
albumin reabsorption by lysine infusion in normal volunteers.
Lower bounds on Cm must be based on estimated upper
bounds on 0. Recall that for a molecule which is neither
secreted nor reabsorbed, the urinary fractional clearance (Ou) is
equal to the Bowman's space-to-plasma concentration ratio (0)
for that molecule. Since plasma proteins are reabsorbed (to
varying degrees), the urinary fractional clearance underes-
timates 0. For both MCN and control groups, reasonable
assumptions about the extent of albumin reabsorption allow
estimation of an upper bound on 6, denoted by 0max Numerous
micropuncture experiments in normal and nephrotic rats allow
calculation of the fractional reabsorption of albumin. In a group
of such studies reviewed by Galaske, Baldamus, and Stolte
[32], the fraction of filtered albumin reabsorbed varied from 57
Table 2. Model inputs for man
0I
E
E
E
E
32
28
24
20
16
12
8
4
0
Glomerular pore radius calculated from neutral dextran clearances.
' Total protein charge concentration in systemic plasma; z, is as-
sumed to be constant.
Total cation concentration in systemic plasma.
Urinary fractional clearance.
NL
I I - -- I I
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to 96% in normal rats and from 16 to 20% in rats with
glomerulopathy induced by antiglomerular basement membrane
antibody. If we denote the urinary fractional clearance (without
lysine) as 6u then conservative assumptions are that 6max = 100
6u normally, and °max = 5 6u in MCN. Thus, based on the
values in Table 2 for man, 6max = 1.7 x iO normally, and °max
= 8.75 x io in MCN. This is equivalent to the assumption
that less than 99% of filtered albumin is reabsorbed normally,
and less than 80% of filtered albumin is reabsorbed with
nephrotic levels of proteinuria in MCN. The corresponding
lower bounds on Cm are 140 mEq/liter in normal individuals and
60 mEq/liter in MCN, as shown in Table 3. Thus, the best
estimates of 6 for albumin give charge values ranging from 140
to 160 mEq/liter in normal individuals and 60 to 90 mEq/liter in
MCN.
The estimates of Cm in Table 3 are based on the assumption
that AP = 40 mm Hg in each experimental condition. The effect
on these calculations of the assumed value of P is shown in
Table 4. Measured values of ITE discussed above indicate that
P> 39 mm Hg in normal individuals and P> 26 mm Hg in
MCN. As indicated in Table 4, little or no effect on the
calculated Cm is observed when zP is varied throughout the
probable physiological range for normal subjects (40 to 50 mm
Hg) or patients with MCN (30 to 50 mm Hg). The variations in
Cm due to the uncertainty in P are only 0 to 8%. Thus, the
unavailability of micropuncture data on zP for humans does not
seriously hinder the quantitative estimation of membrane
charge.
Discussion
The calculated upper bounds on Cm in humans based on
normal urinary fractional clearances (220 to 480 mEq/liter) are
well above the actual range of values for Cm (100 to 170 mEq/
liter) in normal Munich-Wistar rats [7, 8]. This discrepancy is
undoubtedly due largely to tubule reabsorption of albumin,
salivary amylase, and transferrin. From the data of Mogenson
and SoIling [171, one can estimate that normal reabsorption
rates of albumin and transferrin exceed 97 and 99%, respective-
ly, of the filtered loads. Since the ratio of amylase to creatinine
Table 3. Estimates of glomerular wall fixed negative charge density
Crn(mEq/liter)'
Protein
Upper bound
C,,,
Lower boundb
C,,,
Normal
Albumin 220 140
Transferrin 480 —
Amylase 305 —
Lysine infusion
Albumin 160 —
Transferrin 260 —
Minimal change nephropathy
Albumin 90 60
clearance is constant over a wide range of GFR and serum
amylase concentrations, past authors concluded that amylase is
not reabsorbed significantly [351. However, amylase reabsorp-
tion was demonstrated in rats in a later study by Noda using
stop-flow analysis [36]. More recently, direct measurements of
the clearance of salivary isoamylase showed four to fivefold
increases during acute pancreatitis, suggesting that at least 75%
of filtered amylase is reabsorbed normally [181. Thus, the
precise degrees of albumin, transferrin, and amylase reabsorp-
tion are not known, but it is fairly certain that reabsorption of
these three proteins is normally not negligible. For this reason,
estimates of Cm based on albumin and transferrin clearances
during inhibition of protein reabsorption by lysine infusion (160
to 260 mEq/liter) should be much more accurate than those
obtained from normal urinary clearances. These estimates are
dependent of course on the assumption that lysine infusion
selectively inhibits tubule protein reabsorption while not alter-
ing the glomerular barrier, as argued by Mogenson and Soiling
[17]. Fractional clearance measurements during lysine infusion
for nonreabsorbed macromolecules (such as dextran) would
provide a good test of this assumption, but such data are not
currently available.
The molecular charge of transferrin at physiologic pH, —9.4
Eq/mole, was found to be one-half that of albumin. Since the
molecular radius of transferrin (38 A) is similar to that of
albumin (36 A), electrostatic interactions with the fixed nega-
tive charges on the glomerular capillary wall should cause
albumin fractional clearance to be less than that of transferrin.
In accord with this expectation, the urinary fractional clearance
(Ou) of transferrin is approximately twice that of albumin, when
tubule protein reabsorption has been reduced substantially by
lysine infusion (Table 2). In contrast, one would expect clear-
ances of these two proteins to be more similar during any form
of glomerular injury in which charge selectivity is impaired.
Almost precise equivalence between albumin and transferrin
clearances has indeed been observed frequently in a variety of
human glomerulopathies, including MCN [33, 34]. On a more
quantitative level, the higher "upper bound" value of Cm
obtained for transferrin than for albumin (260 versus 160 mEq/
liter) indicates that, according to the theoretical model, the
normal ratio of transferrin to albumin clearance (neglecting
reabsorption) should be even larger than the observed ratio of
62 —
58 —
NL
54
50 —
MCN
46 I I Values were calculated to the nearest 5 mEq/liter.28 32 36 40 44 48 52 Assumes < 99% reabsorption of albumin normally and < 80%P, mm Hg reabsorption of albumin in minimal change nephropathy.
Fig. 4. Pore radius, r,,, as a function of the assumed value of P,
calculated from neutral dextran clearances. In MCN, pore radius is not
increased relative to normal (NL), assuming no large changes in P.
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Table 4. Sensitivity of estimates of C,,, to uncertainty in P
Protein
Upper bound
C,,,
Lower bound
C,,,
Normal,
=40 -*50 mm Hg
Albumin (220 —* 220) (140 —* 140)
Transferrin (480 —* 520) —
Amylase (305 —* 325) —
Lysine infusion,
= 40— 50mm Hg
Albumin (160—* 160) —
Transferrin (260 — 290) —
Minimal change nephropathy,
= 30
-*50 mm Hg
Albumin (85 —* 90) (60 —* 65)
1.9, approximately 60. Whether this discrepancy in Cmvalues is
due to greater residual reabsorption of transferrin than that of
albumin during lysine infusion, or to some effect (like differ-
ences in molecular configuration) not included in the model,
cannot be determined at this time. Until a better understanding
is available of both protein reabsorption kinetics and effects of
molecular configuration on filtration, inferences regarding dif-
ferences in Cm between normal and pathological states should
be based on data for the same macromolecule.
The changes in membrane properties (Kr, r0, Cm) of the
human glomerulus due to MCN are remarkably similar to those
reported previously for a morphologically similar disorder in
rats, puromycin aminonucleoside nephrosis (PAN) [7, 11]. In
PAN rats, Kf determined from direct micropuncture measure-
ments of the required input quantities (including P) was
reduced by approximately 70% compared to normal controls
[111; depending on the assumed values of zP in humans, we
infer Kf in MCN to be reduced by approximately 50 to 75%
(Fig. 3). Effective pore radius (r0) was virtually unchanged in
PAN and MCN, perhaps decreasing slightly. This implies a
large reduction in the number of filtering pores, perhaps accom-
panied by an increase in their length. Similar conclusions for
MCN were reached by Winetz et al [37]. The reduction in Cm
inferred here from the albumin data (140 to 160 mEq/liter in
normal individuals to 60 to 90 mEq/liter in MCN) again is quite
similar to that calculated for PAN rats [7], based on fractional
clearances of dextran derivatives (120 to 170 mEq/liter in
controls to 100 mEq/liter in PAN). Thus, the proteinuria both in
PAN rats and in humans with MCN is most readily explained by
a 40 to 50% loss of fixed negative charges from the glomerular
capillary wall.5 As shown by the results in Table 4, the
unavailability of P measurements in humans has little effect on
the charge estimates.
Albumin filtration in PAN rats is at least roughly approximated by
the measured total rate of protein excretion [11], since proteinuria in
this disorder is highly selective and fractional reabsorption of albumin is
probably quite small. Assuming this to be true, we calculate that Cm =
70 mEq/liter in PAN is sufficient to account for the observed level of
proteinuria. Although this charge concentration in PAN rats is some-
what lower than that obtained from the dextran data (100 mEq/liter), it
still represents a 40 to 50% reduction below the corresponding Cm
values calculated from albumin data in normal animals, 100 to 130 mEq/
liter [81.
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